FFCP PHASE1:Mm9::chr17:34442013..34442020,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=48|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr17:34442013..34442020,+|id=chr17:34442013..34442020,+|ontology_enrichment_celltype=CL:0000553!3.72e-24!6;CL:0000556!3.72e-24!6;CL:0000050!2.96e-16!9;CL:0000414!2.26e-13!11;CL:0002031!1.01e-12!25;CL:0000839!2.28e-11!13;CL:0000945!1.63e-10!1;CL:0000236!1.63e-10!1;CL:0000826!1.63e-10!1;CL:0000988!6.51e-10!32;CL:0002032!6.51e-10!32;CL:0000037!6.51e-10!32;CL:0000566!6.51e-10!32;CL:0000837!6.51e-10!32;CL:0000763!2.69e-09!16;CL:0000063!3.39e-08!66;CL:0000049!7.13e-08!19;CL:0002320!7.69e-07!46;CL:0000134!7.69e-07!46|ontology_enrichment_celltype_v019_2=CL:0000945,3.07e-86,1;CL:0000236,3.07e-86,1;CL:0000826,3.07e-86,1;CL:0000838,1.13e-08,12;CL:0000542,4.08e-08,13;CL:0000051,4.08e-08,13|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0000993!6.88e-10!1;UBERON:0002371!2.69e-09!16;UBERON:0002384!7.69e-07!46;UBERON:0001474!7.81e-07!22;UBERON:0004765!7.81e-07!22;UBERON:0001434!7.81e-07!22|ontology_enrichment_uberon_v019_2=|phase1_expression=0,0,0,0,0,0,0.233612640595526,0,0,0,0,0,0,0.0874204024189974,0,0.202475267389826,0,0.946386496074713,0.274228867211478,0.42438965179803,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.166234645358492,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.53013036355888,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.164970122972535,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.139951452323658,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr17:34442013..34442020,+}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=48 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr17:34442013..34442020,+ | |||
|description=CAGE_peak_at_chr17:34442013..34442020,+ | |||
|id=chr17:34442013..34442020,+ | |||
|ontology_enrichment_celltype=CL:0000553!3.72e-24!6;CL:0000556!3.72e-24!6;CL:0000050!2.96e-16!9;CL:0000414!2.26e-13!11;CL:0002031!1.01e-12!25;CL:0000839!2.28e-11!13;CL:0000945!1.63e-10!1;CL:0000236!1.63e-10!1;CL:0000826!1.63e-10!1;CL:0000988!6.51e-10!32;CL:0002032!6.51e-10!32;CL:0000037!6.51e-10!32;CL:0000566!6.51e-10!32;CL:0000837!6.51e-10!32;CL:0000763!2.69e-09!16;CL:0000063!3.39e-08!66;CL:0000049!7.13e-08!19;CL:0002320!7.69e-07!46;CL:0000134!7.69e-07!46 | |||
|ontology_enrichment_celltype_v019_2=CL:0000945,3.07e-86,1;CL:0000236,3.07e-86,1;CL:0000826,3.07e-86,1;CL:0000838,1.13e-08,12;CL:0000542,4.08e-08,13;CL:0000051,4.08e-08,13 | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0000993!6.88e-10!1;UBERON:0002371!2.69e-09!16;UBERON:0002384!7.69e-07!46;UBERON:0001474!7.81e-07!22;UBERON:0004765!7.81e-07!22;UBERON:0001434!7.81e-07!22 | |||
|ontology_enrichment_uberon_v019_2= | |||
|phase1_expression=0,0,0,0,0,0,0.233612640595526,0,0,0,0,0,0,0.0874204024189974,0,0.202475267389826,0,0.946386496074713,0.274228867211478,0.42438965179803,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.166234645358492,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.53013036355888,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.164970122972535,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.139951452323658,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr17:34442013..34442020,+ | |||
}} |
Latest revision as of 17:15, 4 August 2015
Short description: | p@chr17:34442013..34442020, + |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr17:34442013..34442020, + |
Coexpression cluster: | MCL_coexpression_mm9:48 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
lymphocyte of B lineage | 3.07e-86 | 1 |
B cell | 3.07e-86 | 1 |
pro-B cell | 3.07e-86 | 1 |
lymphoid lineage restricted progenitor cell | 1.13e-08 | 12 |
lymphocyte | 4.08e-08 | 13 |
common lymphoid progenitor | 4.08e-08 | 13 |